Rainmed MedicalHKSE:02297 49 Net Margin % is -512.05% as of Dec. 2025. GuruFocus rates HKSE:02297 with a GF Score™ of 49/100 and a GF Value™ of HK$0.08 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Rainmed Medical ranks worse than 90.2% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Rainmed Medical's Net Income for the
six
months ended in Dec. 2025 was HK$-49.62 Mil. Rainmed Medical's Revenue for the
six
months ended in Dec. 2025 was HK$9.69 Mil. Therefore, Rainmed Medical's net margin for the quarter that ended in Dec. 2025 was -512.05%.
The historical rank and industry rank for Rainmed Medical's Net Margin % or its related term are showing as below:
HKSE:02297'
s Net Margin % Range Over the Past 10 Years
Min: -2382.01 Med: -591.17 Max: -158.2
Current: -402.51
HKSE:02297's Net Margin % is ranked worse than 90.2% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs HKSE:02297: -402.51
Rainmed Medical (HKSE:02297) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Rainmed Medical Net Margin % Related Terms
Rainmed Medical Net Margin % Historical Data
* Premium members only.
The historical data trend for Rainmed Medical's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02297 vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Rainmed Medical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rainmed Medical Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Rainmed Medical's Net Margin % distribution charts can be found below:
* The bar in red indicates where Rainmed Medical's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rainmed Medical (HKSE:02297) has a Net Margin % of -512.05% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Rainmed Medical and its competitors. According to the industry distribution chart, Rainmed Medical ranks #736 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 90.2%.
Is Rainmed Medical's Net Margin % too high?
Rainmed Medical's current Net Margin % is -512.05%. Based on the distribution chart, Rainmed Medical ranks #736 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Rainmed Medical has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rainmed Medical's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Rainmed Medical ranks #736 out of 816 companies for Net Margin %. This places Rainmed Medical in the lower half of its industry. The industry median Net Margin % is 2.06. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.06, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Rainmed Medical and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rainmed Medical's current Net Margin % is -512.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rainmed Medical stock overvalued right now?
Based on GuruFocus' analysis, Rainmed Medical (HKSE:02297) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.08, compared to a current price of HK$0.22 — trading 175% above its estimated fair value. The current Net Margin % is -512.05%. Rainmed Medical's overall GF Score™ is 49/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Rainmed Medical (HKSE:02297), the current Net Margin % is -512.05% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rainmed Medical (HKSE:02297) Overvalued in 2026?
Based on GuruFocus' analysis, Rainmed Medical stock appears to be overvalued.
The current stock price of HK$0.22 is trading 175% above its estimated GF Value™ of HK$0.08.
GuruFocus considers Rainmed Medical to be Significantly Overvalued.
Key valuation signals for HKSE:02297:
Net Margin %: -512.05%
GF Value™: HK$0.08 vs. price of HK$0.22 (175% above fair value)
No single metric tells the full story. See the HKSE:02297 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rainmed Medical Ltd is focused on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microcirculatory resistance systems. The company's core products, the caFFR system and the caIMR system, are medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD). It operates in China and Other countries.
49GF Score
Get the complete analysis for HKSE:02297
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02297 has been successfully added to your 
